drugset / Trial / NCT06800729
A Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of TIX100 in Healthy Subjects
RandomizedSingle-groupQuadruple-blindTreatment
Summary
A Single Center, Single Dose, Randomized, Placebo-controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
Timeline
- Start
- 2025-01
- Primary completion
- 2025-05
- Completion
- 2025-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | TIX100 | Unknown | 20 mg | Oral |
| Comparator | TIX100 | Unknown | 60 mg | Oral |
| Comparator | TIX100 | Unknown | 100 mg | Oral |
| Comparator | TIX100 | Unknown | 160 mg | Oral |
| Comparator | TIX100 | Unknown | 200 mg | Oral |
Indications
No indication recorded.